FDA approves first drug for NASH — a severe form of fatty liver disease

A Yale Medicine expert discusses Rezdiffra, a new treatment for a serious subtype of fatty liver disease that is not caused by heavy alcohol use.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news